ArticleEvolutionary applications2015
Fighting microbial drug resistance: a primer on the role of evolutionary biology in public health.
Article in Evolutionary applications, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- Investigating the distribution of antibiotic resistance genes in relation to bacterial, fungal, and functional diversity in a hay field.Microbiology spectrum · 2026Article
- Meeting Report on the Symposium "Evolutionary Applications" at the 3rd Joint Congress on Evolutionary Biology.Evolutionary applications · 2025Article
- Context-dependent fitness benefits of antibiotic resistance mutations.Proceedings. Biological sciences · 2024Article
- Towards evolutionary predictions: Current promises and challenges.Evolutionary applications · 2023Review
- Using ecological coexistence theory to understand antibiotic resistance and microbial competition.Nature ecology & evolution · 2021Review
- Asynchrony between virus diversity and antibody selection limits influenza virus evolution.eLife · 2020Article
- Multidrug Resistance (MDR) and Collateral Sensitivity in Bacteria, with Special Attention to Genetic and Evolutionary Aspects and to the Perspectives of Antimicrobial Peptides-A Review.Pathogens (Basel, Switzerland) · 2020Review
- Genomic Comparison Reveals Natural Occurrence of Clinically Relevant Multidrug-Resistant Extended-Spectrum-β-Lactamase-Producing Escherichia coli Strains.Applied and environmental microbiology · 2019Article
- Antibiotic Treatment Drives the Diversification of the Human Gut Resistome.Genomics, proteomics & bioinformatics · 2019Article
- Slow and temperature-mediated pathogen adaptation to a nonspecific fungicide in agricultural ecosystem.Evolutionary applications · 2018Article
- Surface deposited one-dimensional copper-doped TiO2 nanomaterials for prevention of health care acquired infections.PloS one · 2018Article
- The One Health Concept: 10 Years Old and a Long Road Ahead.Frontiers in veterinary science · 2018Review
- Environmental factors influencing the development and spread of antibiotic resistance.FEMS microbiology reviews · 2018Review
- With a little help from my friends: cooperation can accelerate the rate of adaptive valley crossing.BMC evolutionary biology · 2017Article
- Mutations Associated with Decreased Susceptibility to Seven Antimicrobial Families in Field and Laboratory-Derived Mycoplasma bovis Strains.Antimicrobial agents and chemotherapy · 2017Article
- Manipulating virulence factor availability can have complex consequences for infections.Evolutionary applications · 2017Article
- Molecular and cellular bases of adaptation to a changing environment in microorganisms.Proceedings. Biological sciences · 2016Review
- Iron availability shapes the evolution of bacteriocin resistance in Pseudomonas aeruginosa.The ISME journal · 2016Article
- Perspectives on the evolutionary ecology of arthropod antimicrobial peptides.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2016Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Although microbes have been evolving resistance to antimicrobials for millennia, the spread of resistance in pathogen populations calls for the development of new drugs and treatment strategies. We propose that successful, long-term resistance management requires a better understanding of how resistance evolves in the first place. This is an opportunity for evolutionary biologists to engage in public health, a collaboration that has substantial precedent. Resistance evolution has been an important tool for developing and testing evolutionary theory, especially theory related to the genetic basis of new traits and constraints on adaptation. The present era is no exception. The articles in this issue highlight the breadth of current research on resistance evolution and also its challenges. In this introduction, we review the conceptual advances that have been achieved from studying resistance evolution and describe a path forward.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.